A collection of ultrasonic data unique in the world

This clinical trial marks a key milestone for research enabling the collection of unique ultrasound data in the world for brain exploration. This advance is the result of close collaboration between Caen Normandie University Hospital and Resolve Stroke, a company specializing in neuroimaging solutions.

The company Resolve Stroke has made its new platform available to Caen Normandy University Hospital aimed at evaluating cerebral blood flow directly at the patient's bedside. This non-invasive technique offers real hope to critically ill patients with brain injuries, helping doctors reduce the high risk of delayed complications.

Thanks to the unique architecture of the SYLVER platform, Caen Normandie University Hospital can acquire large sets of raw data covering a wide field of view with exceptional speed. The computing power of Nvidia graphics processors, combined with Resolve Stroke's software engine, enables the full use of ultrasound data to transform the diagnosis and treatment of neurological diseases.

All necessary authorizations from the competent French authorities have been obtained to conduct this clinical trial.

This collaboration strengthens the potential impact of the trial and ensures access to expertise in neuro-intensive care.

Thanks to this progress, Caen Normandie University Hospital demonstrates its commitment to supporting research in neurology.

The clinical ultrasound data collected in this study will open new opportunities for the research and development of innovative medical solutions.